Keywords: Watson Pharma, Itero Biopharma, Females infertility, rFSH, Biosimilars, Licensing

Watson and Itero sign worldwide license deal on biologic development candidate for female infertility

Article | 16 July 2010

Watson Pharmaceuticals has entered an exclusive, worldwide licensing agreement with fellow USA-based Itero Biopharmaceuticals, a venture-backed specialty biopharmaceutical company, to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Itero Biopharmaceuticals

Watson Pharmaceuticals

Go to company listing